Any insurers with a stake in the well-being of the elderly ought to do what they can to buffer dementia research projects from government budget woes.
The UsAgainstAlazheimer’s Network is helping to support another group, ResearchersAgainstAlzheimer’s. Both groups are trying to persuade members of Congress from protecting federal Alzheimer’s research projects, and other dementia research projects, against funding cuts related to all of the problems with the federal budget deficit, sequestration, etc. etc.
My suspicion is that, whenever I get e-mails about admirable grassroots groups founded by, for example, people with loved ones affected by Alzheimer’s, chances are there’s a pharmaceutical company or something like that behind the effort.
In this case: Great! The more the merrier. The bigger the conspiracy to get rid of Alzheimer’s and other causes of dementia, the better.
Of course: If any researchers are squandering the money or doing terrible research, let’s send them on a long sabbatical in North Korea.
But, if they’re doing good, efficient research: What better investment can the country make?